Meeting
2018 ASCO Annual Meeting
Concurrent genomic alterations in lung adenocarcinoma with a MET exon 14 skipping mutation.
Authors
Julia Rotow
University of California, San Francisco, San Francisco, CA
Julia Rotow , Wei Wu , Collin M. Blakely , Richard B. Lanman , Victoria M. Raymond , Frederic J. Kaye , Phillipe Gui , James Fraser , Alexander Wolff , Eric Andrew Collisson , Caroline Elizabeth McCoach , Trever Grant Bivona
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 36, 2018 (suppl; abstr 9083)
DOI
10.1200/JCO.2018.36.15_suppl.9083
Abstract #
9083
Poster Bd #
406
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Genomic alterations in appendiceal carcinoma using circulating DNA.
First Author: Walid Labib Shaib
Poster
2023 ASCO Annual Meeting
Updated molecular analysis of MET exon 14 skipping mutations (METex14) in non-small cell lung cancer (NSCLC).
First Author: Jennifer Aline Marks
Poster
2022 ASCO Annual Meeting
Molecular characterization of NF1-mutated NSCLC and clinical outcomes.
First Author: Christopher Gates
Poster
2021 ASCO Annual Meeting
Targeted ctDNA sequencing analysis reveals concurrent genomic alterations and its impact on TKI and immune checkpoint inhibitor therapy in advanced NSCLC from Asian population.
First Author: Wei Wu